Replication and Meta-Analysis of 13, 000 Cases Defines the Risk for Interleukin-23 Receptor and Autophagy-Related 16-Like 1 Variants in Crohn's Disease. (2010)

• Record Type: Journal Article
• Authors: Cotterill, Lynn; Payne, Debbie; Levison, Scott; McLaughlin, John; Wesley, Emma; Feeney, Mark; Durbin, Hilary; Lal, Simon; Makin, Alistair; Campbell, Simon; Roberts, Stephen A; O'Neill, Catherine; Edwards, Cathryn; Newman, William G
• Is Part Of: Canadian Journal of Gastroenterology. Volume 24:Number 5(2010)
• Page Start: 297
• Page End: 302
• Publication Date: 2010
• DOI: 10.1155/2010/480458
• Languages: English
• ISSNs: 0835-7900

Abstract

Abstract : BACKGROUND/OBJECTIVE: Variants in the interleukin-23 receptor ( IL23R ) and the autophagy-related 16-like 1 ( ATG16L1 ) genes have been associated with an increased risk of Crohn's disease (CD). Both genes were identified through genome-wide association scans and subsequent studies have validated these associations. To assess the effect size of these variants, an independent case-control association study and meta-analysis were performed. METHODS: British Caucasian subjects with inflammatory bowel disease (n=500) and 877 ethnically matched controls were genotyped for the disease-associated variants in IL23R and ATG16L1 . In addition, meta-analyses of 12, 991 patients and 14, 598 controls, and 11, 909 patients and 15, 798 controls, were conducted on independently published data for the associations between IL23R and ATG16L1 variants and CD, respectively. RESULTS: In the present cohort, both susceptibility variants showed highly significant associations, including IL23R (rs11209026, P=0.0006; OR 0.37; 95% CI 0.21 to 0.67) and ATG16L1 (rs2241880, P=0.0017; OR 1.36; 95% CI 1.12 to 1.66). The meta-analysis based on the random effects model showed similar combined effects for rs11209026 (n=26, OR 0.41; 95% CI 0.37 to 0.46) and rs2241880 (n=25, OR 1.33; 95% CI 1.28 to 1.39). There was no statistically significant gene-gene interaction between caspase recruitment domain ( CARD15 ) variants and the IL23R or ATG16L1 polymorphisms (P=0.44 and P=0.24, respectively). CONCLUSION: The present cohort and meta-analysis provides strong evidence that, in addition to CARD15, polymorphisms in both IL23R and ATG16L1 alter susceptibility to CD and that these effects are consistent across all populations of European ancestry; however, only ATG16L1 is relevant to inflammatory bowel disease in the Asian population.